2011 Industry Operations Pharmaceuticals 
Strategy Driven
JULY 13, 2011
Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth. As with the other measures, what is important varies by industry. We advocate that companies choose their own set of metrics tailored to their industries and strategies.
Harvard Business Review
MARCH 2, 2011
Meanwhile behemoths such as McKinsey and BCG, to maintain their above-industry-average growth rates and keep their global office networks humming, have broadened what they do and moved down the food chain. Or redesigning a company's entire store system and approach to customers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
MAY 20, 2014
The rate of business formation in 2011 was almost half of what it was in 1978, with the rate of dissolution somewhat higher than the past couple decades. Consolidation of the financial sector has led to similar dynamics in other industries. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers.
Strategy Driven
MARCH 18, 2011
We’ve established a strong correlation between coherence, as we define it, and superior performance over time in a number of industries. Those companies that focus on building a system of three to six best-in-class, interlocking capabilities that support their way to play achieve a right to win in their industries.
Harvard Business Review
FEBRUARY 24, 2015
The first category is exogenous factors over which the business has little control: the growth of the markets into which it sells; the competitive intensity and thus the average profitability of the industry in which it operates; or the fragmentation of its industry and thus the scope for a growth-by-acquisition approach.
Harvard Business Review
JUNE 16, 2016
By the mid-1980’s, the American semiconductor industry seemed like it was doomed. So in 1986, the American government created SEMATECH , a consortium of government agencies, research institutions and private industry. The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011.
Strategy Driven
JANUARY 24, 2011
Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.
Expert insights. Personalized for you.
62 
Let's personalize your content